New hepatic targets for glycaemic control in diabetes
Author:
- 1 December 2007
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Endocrinology & Metabolism
- Vol. 21 (4) , 587-605
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- FR258900, a potential anti‐hyperglycemic drug, binds at the allosteric site of glycogen phosphorylaseProtein Science, 2007
- Novel thienopyrrole glycogen phosphorylase inhibitors: Synthesis, in vitro SAR and crystallographic studiesBioorganic & Medicinal Chemistry Letters, 2006
- Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation state of the enzymeBritish Journal of Pharmacology, 2006
- Predictive blood glucose lowering efficacy by Glucokinase activators in high fat fed female Zucker ratsBritish Journal of Pharmacology, 2006
- Discovery, synthesis and biological evaluation of novel glucokinase activatorsBioorganic & Medicinal Chemistry Letters, 2005
- Evidence against Glycogen Cycling of Gluconeogenic Substrates in Various Liver PreparationsJournal of Biological Chemistry, 2002
- Acute Inhibition of Hepatic Glucose-6-phosphatase Does Not Affect Gluconeogenesis but Directs Gluconeogenic Flux toward Glycogen in Fasted RatsJournal of Biological Chemistry, 2001
- Glucose-6-phosphatase Overexpression Lowers Glucose 6-Phosphate and Inhibits Glycogen Synthesis and Glycolysis in Hepatocytes without Affecting Glucokinase TranslocationJournal of Biological Chemistry, 1999
- Liver Glucokinase: Decreased Activity in Patients with Type II DiabetesHormone and Metabolic Research, 1995
- Hepatic Enzyme Activities of Glycolysis and Gluconeogenesis in Diabetes of Man and Laboratory AnimalsHormone and Metabolic Research, 1970